^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Celeuk (celmoleukin)

    Associations
    News

    Trials

    Company:
    Takeda
    Drug class:
    Immunostimulant, IL-2 stimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression. (EMR 62206-016) (NCT00408967)
    Phase 2
    EMD Serono
    Withdrawn
    Last update posted :
    08/18/2017
    Initiation :
    12/31/2006
    Primary completion :
    05/31/2008
    Completion :
    05/31/2008
    EPCAM
    |
    EPCAM expression
    |
    cyclophosphamide • Celeuk (celmoleukin)